By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Three Dutch institutes have joined forces in a public-private partnership to invest €28 million in personalized medicine projects, they announced today.

The three groups — the BioMedical Materials Program, the Center for Translational Molecular Medicine, and the Top Institute Pharma — have already selected seven projects that will receive funding from the collaboration. The projects will focus on personalized medicine research in cardiovascular diseases and cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.